Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Clinical trial NCT02717156 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02717156
Sponsor: University of Southern California
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Bladder Urothelial Carcinoma Prostate Cancer Urothelial Carcinoma

Start date: 2016-11-21
Primary completion: 2027-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.